pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Doxepin Hydrochloride
drug
save

doxepin hydrochloride

Marketedupdated 3mo ago
by RK Pharma Inc
Approved
community read0 votes

🐶 often sniffed alongside

top 3
  • companyAlembic Pharmaceuticals Inc3 co-mentions · 1 sources
  • drugZonalon1 co-mentions · 1 sources
  • tagRecall1 co-mentions · 1 sources

indications

investigational
Major Depression

all catalysts(0)

nothing on the calendar yet

Patent cliff

source: FDA Orange Book
first barrier falls
May 18, 2027
270 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (32)

  • Sep 7, 2030method-of-use (U-620)US 85132994.0y
  • Sep 7, 2030method-of-use (U-620)US 85132994.0y
  • Jun 1, 2029formulationUS 95329712.8y
  • Jun 1, 2029formulationUS 95329712.8y
  • May 1, 2028method-of-use (U-620)US 91078981.7y
  • May 1, 2028method-of-use (U-620)US 91078981.7y
  • Apr 11, 2028method-of-use (U-620)US 105488711.6y
  • Apr 11, 2028method-of-use (U-620)US 105488711.6y
  • Apr 11, 2028method-of-use (U-620)US 110969201.6y
  • Apr 11, 2028method-of-use (U-620)US 110969201.6y
  • Apr 11, 2028formulationUS 99077801.6y
  • Apr 11, 2028formulationUS 99077801.6y
  • Jan 18, 2028method-of-use (U-620)US 112349541.4y
  • Jan 18, 2028method-of-use (U-620)US 112349541.4y
  • Aug 24, 2027method-of-use (U-620)US 79153071.0y
  • Aug 24, 2027method-of-use (U-620)US 79153071.0y
  • Jul 20, 2027method-of-use (U-620)US 10653660333d
  • Jul 20, 2027method-of-use (U-620)US 10653660333d
  • Jul 20, 2027method-of-use (U-620)US 11110074333d
  • Jul 20, 2027method-of-use (U-620)US 11110074333d
  • Jul 20, 2027method-of-use (U-620)US 9572814333d
  • Jul 20, 2027method-of-use (U-620)US 9572814333d
  • May 18, 2027method-of-use (U-620)US 10238620270d
  • May 18, 2027method-of-use (U-620)US 10238620270d
  • May 18, 2027method-of-use (U-620)US 10653662270d
  • May 18, 2027method-of-use (U-620)US 10653662270d
  • May 18, 2027method-of-use (U-620)US 12083090270d
  • May 18, 2027method-of-use (U-620)US 12083090270d
  • May 18, 2027method-of-use (U-620)US 9486437270d
  • May 18, 2027method-of-use (U-620)US 9486437270d
  • May 18, 2027method-of-use (U-620)US 9861607270d
  • May 18, 2027method-of-use (U-620)US 9861607270d

News(0)

no news has mentioned this drug yet

brand
Doxepin Hydrochloride
generic
doxepin hydrochloride
indication
Anxiety Disorders
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 18m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?